EDSA logo

Edesa Biotech (EDSA) Operating Profit

Annual Operating Profit

-$6.32 M
+$2.33 M+26.91%

September 30, 2024


Summary


Performance

EDSA Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherEDSAprofitabilitymetrics:

Quarterly Operating Profit

-$967.20 K
+$729.00 K+42.98%

September 30, 2024


Summary


Performance

EDSA Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherEDSAprofitabilitymetrics:

TTM Operating Profit

-$6.32 M
+$821.40 K+11.51%

September 30, 2024


Summary


Performance

EDSA TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherEDSAprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

EDSA Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+26.9%+49.5%+15.8%
3 y3 years+52.6%+53.1%+34.8%
5 y5 years-123.0%+53.1%+34.8%

EDSA Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+64.1%at high+83.3%at high+65.6%
5 y5-year-123.0%+64.1%at high+83.3%-28.6%+65.6%
alltimeall time-7946.5%+64.1%-179.4%+83.3%<-9999.0%+65.6%

Edesa Biotech Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-$6.32 M(-26.9%)
-$967.20 K(-43.0%)
-$6.32 M(-11.5%)
Jun 2024
-
-$1.70 M(-11.5%)
-$7.14 M(-4.9%)
Mar 2024
-
-$1.92 M(+10.4%)
-$7.51 M(-6.2%)
Dec 2023
-
-$1.74 M(-2.9%)
-$8.00 M(-7.4%)
Sep 2023
-$8.64 M(-50.9%)
-$1.79 M(-13.4%)
-$8.64 M(-10.8%)
Jun 2023
-
-$2.06 M(-14.4%)
-$9.69 M(-27.8%)
Mar 2023
-
-$2.41 M(+1.4%)
-$13.42 M(-13.9%)
Dec 2022
-
-$2.38 M(-16.1%)
-$15.59 M(-11.4%)
Sep 2022
-$17.59 M(+31.9%)
-$2.84 M(-51.1%)
-$17.59 M(-4.3%)
Jun 2022
-
-$5.80 M(+26.7%)
-$18.38 M(+5.9%)
Mar 2022
-
-$4.58 M(+4.4%)
-$17.34 M(+14.8%)
Dec 2021
-
-$4.38 M(+21.0%)
-$15.11 M(+13.3%)
Sep 2021
-$13.34 M(+108.4%)
-$3.62 M(-24.0%)
-$13.34 M(+13.7%)
Jun 2021
-
-$4.77 M(+103.7%)
-$11.73 M(+34.3%)
Mar 2021
-
-$2.34 M(-10.5%)
-$8.73 M(+10.4%)
Dec 2020
-
-$2.61 M(+30.0%)
-$7.91 M(+23.6%)
Sep 2020
-$6.40 M(+126.0%)
-$2.01 M(+13.7%)
-$6.40 M(+19.4%)
Jun 2020
-
-$1.77 M(+16.6%)
-$5.36 M(+9.1%)
Mar 2020
-
-$1.52 M(+37.1%)
-$4.91 M(-3.3%)
Dec 2019
-
-$1.11 M(+13.9%)
-$5.08 M(-5.6%)
Sep 2019
-$2.83 M(-44.2%)
-$971.00 K(-26.5%)
-$5.38 M(-3.8%)
Jun 2019
-
-$1.32 M(-21.6%)
-$5.60 M(+3.0%)
Mar 2019
-
-$1.68 M(+19.7%)
-$5.43 M(+6.7%)
Dec 2018
-
-$1.41 M(+18.6%)
-$5.09 M(+0.3%)
Sep 2018
-$5.08 M(-2.8%)
-$1.19 M(+2.4%)
-$5.08 M(-3.5%)
Jun 2018
-
-$1.16 M(-13.8%)
-$5.26 M(-2.5%)
Mar 2018
-
-$1.34 M(-3.3%)
-$5.40 M(+3.8%)
Dec 2017
-
-$1.39 M(+1.5%)
-$5.20 M(-0.5%)
Sep 2017
-$5.22 M(+6.4%)
-$1.37 M(+5.8%)
-$5.22 M(+1.0%)
Jun 2017
-
-$1.29 M(+12.7%)
-$5.17 M(+2.1%)
Mar 2017
-
-$1.15 M(-18.9%)
-$5.07 M(+1.0%)
Dec 2016
-
-$1.41 M(+7.4%)
-$5.02 M(+2.2%)
DateAnnualQuarterlyTTM
Sep 2016
-$4.91 M(+13.1%)
-$1.32 M(+10.8%)
-$4.91 M(+8.1%)
Jun 2016
-
-$1.19 M(+8.4%)
-$4.54 M(+7.4%)
Mar 2016
-
-$1.10 M(-16.2%)
-$4.23 M(-2.2%)
Dec 2015
-
-$1.31 M(+37.9%)
-$4.32 M(-0.4%)
Sep 2015
-$4.34 M(+859.2%)
-$948.00 K(+8.3%)
-$4.34 M(-6.8%)
Jun 2015
-
-$875.60 K(-26.4%)
-$4.65 M(-9.4%)
Mar 2015
-
-$1.19 M(-10.2%)
-$5.14 M(-4.7%)
Dec 2014
-
-$1.33 M(+4.8%)
-$5.39 M(-5.7%)
Sep 2014
-$452.30 K(-92.1%)
-
-
Aug 2014
-$5.72 M(+48.6%)
-$1.26 M(-7.0%)
-$5.72 M(-0.7%)
May 2014
-
-$1.36 M(-5.8%)
-$5.76 M(+11.0%)
Feb 2014
-
-$1.44 M(-12.5%)
-$5.19 M(+13.0%)
Nov 2013
-
-$1.65 M(+26.4%)
-$4.59 M(+19.4%)
Aug 2013
-$3.85 M(-41.2%)
-$1.31 M(+65.5%)
-$3.85 M(-10.3%)
May 2013
-
-$789.10 K(-7.0%)
-$4.29 M(-16.2%)
Feb 2013
-
-$848.60 K(-6.2%)
-$5.12 M(-10.0%)
Nov 2012
-
-$904.40 K(-48.3%)
-$5.69 M(-13.0%)
Aug 2012
-$6.55 M(+35.5%)
-$1.75 M(+7.8%)
-$6.55 M(+82.8%)
May 2012
-
-$1.62 M(+14.1%)
-$3.58 M(+9.2%)
Feb 2012
-
-$1.42 M(-19.1%)
-$3.28 M(-43.4%)
Nov 2011
-
-$1.76 M(-244.2%)
-$5.79 M(+19.8%)
Aug 2011
-$4.83 M(+353.5%)
$1.22 M(-192.3%)
-$4.83 M(-24.4%)
May 2011
-
-$1.32 M(-66.4%)
-$6.39 M(+16.7%)
Feb 2011
-
-$3.93 M(+392.3%)
-$5.48 M(+252.0%)
Nov 2010
-
-$798.50 K(+135.1%)
-$1.56 M(+96.0%)
Aug 2010
-$1.07 M(+1257.2%)
-$339.70 K(-16.3%)
-$793.70 K(+74.8%)
May 2010
-
-$406.00 K(+3492.9%)
-$454.00 K(+742.3%)
Jan 2010
-
-$11.30 K(-69.2%)
-$53.90 K(+12.1%)
Oct 2009
-
-$36.70 K(+522.0%)
-$48.10 K(-38.1%)
Apr 2009
-$78.50 K
-$5900.00(+7.3%)
-$77.70 K(+8.2%)
Jan 2009
-
-$5500.00(-91.7%)
-$71.80 K(+8.3%)
Oct 2008
-
-$66.30 K
-$66.30 K

FAQ

  • What is Edesa Biotech annual operating income?
  • What is the all time high annual operating profit for Edesa Biotech?
  • What is Edesa Biotech annual operating profit year-on-year change?
  • What is Edesa Biotech quarterly operating income?
  • What is the all time high quarterly operating profit for Edesa Biotech?
  • What is Edesa Biotech quarterly operating profit year-on-year change?
  • What is Edesa Biotech TTM operating income?
  • What is the all time high TTM operating profit for Edesa Biotech?
  • What is Edesa Biotech TTM operating profit year-on-year change?

What is Edesa Biotech annual operating income?

The current annual operating profit of EDSA is -$6.32 M

What is the all time high annual operating profit for Edesa Biotech?

Edesa Biotech all-time high annual operating income is -$78.50 K

What is Edesa Biotech annual operating profit year-on-year change?

Over the past year, EDSA annual operating income has changed by +$2.33 M (+26.91%)

What is Edesa Biotech quarterly operating income?

The current quarterly operating profit of EDSA is -$967.20 K

What is the all time high quarterly operating profit for Edesa Biotech?

Edesa Biotech all-time high quarterly operating income is $1.22 M

What is Edesa Biotech quarterly operating profit year-on-year change?

Over the past year, EDSA quarterly operating income has changed by +$949.30 K (+49.53%)

What is Edesa Biotech TTM operating income?

The current TTM operating profit of EDSA is -$6.32 M

What is the all time high TTM operating profit for Edesa Biotech?

Edesa Biotech all-time high TTM operating income is -$48.10 K

What is Edesa Biotech TTM operating profit year-on-year change?

Over the past year, EDSA TTM operating income has changed by +$1.19 M (+15.85%)